Correlation of Increases in 1,25-Dihydroxyvitamin D During Vitamin D Therapy With Activation of CD4+ T Lymphocytes in HIV-1–Infected Males

REFERENCES

• Mora JR, lwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev ImmunoL 2008;8(9):685–698.
   PubMed Web of Science ®Google Scholar
• Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas Sc. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221(4616):1181–1183.
   PubMed Web of Science ®Google Scholar
• Viard JP, Souberbielle JC, Kirk O, et al. Vitamin D and clini-cal disease progression in HIV infection: results from the EuroSIDA study. AIDS. 201125(10):1305–1315.
   Google Scholar
• Haug C, Muller F, Aukrust P, Froland SS. Subnormal serum concentration of 1,25-vitamin D in human immunodefi-ciency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis. 1994;169(4):889–893.
   PubMed Web of Science ®Google Scholar
• Madeddu G, Spanu A, Solinas P, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiv-ing highly active antiretroviral therapy. Q J Nucl Med Mol Imaging. 2004;48(1):39–48.
   PubMed Web of Science ®Google Scholar
• Teichmann J, Stephan E, Discher T, et al. Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection. Metabolism. 2000;49(9):1134–1139.
   PubMed Web of Science ®Google Scholar
• Teichmann J, Stephan E, Lange U, et al. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect. 2003;46(4):221–227.
   PubMed Web of Science ®Google Scholar
• Holmes D, Jiang Q, Zhang L, Su L. Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis. Immunol Res. 2008;41(3):248–266.
   PubMed Web of Science ®Google Scholar
• Gorman S, Kuritzky LA, Judge MA, et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J ImmunoL 2007;179(9):6273–6283.
   PubMed Web of Science ®Google Scholar
• Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 200251(5):1367–1374.
   Google Scholar
• Ardalan MR, Maljaei H, Shoja MM, et al. Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients. Transplant Proc. 2007;39(4):951–953.
   PubMed Web of Science ®Google Scholar
• Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vita-min D treatment for autoimmune diseases? lsr Med Assoc J. 2010;12(3)1 36–139.
   Google Scholar
• Holmes WC, Shea JA. Two approaches to measuring qual-ity of life in the HIV/AIDS population: HAT-QoL and MOS-HIV. Qual Life Res. 1999;8(6):515–527.
   PubMed Web of Science ®Google Scholar
• Geara AS, Castellanos MR, Bassil C, et al. Effects of para-thyroid hormone on immune function. Clin Dev Immunol. 2010;2010:418695. doi: 10.1155/2010/418695
   PubMedGoogle Scholar
• Jeffery LE, Burke F, Mura M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflam-matory cytokines and promote development of regula-tory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183(9):5458–5467.
   PubMed Web of Science ®Google Scholar
• Smolders J, Menheere P, Thewissen M, et al. Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol. 2010;121(1-2):243–246.
   PubMed Web of Science ®Google Scholar
• Abrams D, Levy Y, Losso MH, et al. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009;361(16):1548–1559.
   PubMed Web of Science ®Google Scholar
• Connor RI, Rigby WF. 1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Commun. 1991;176(2): 852–859.
   PubMed Web of Science ®Google Scholar
• Kizaki M, Ikeda Y, Simon KJ, Nanjo M, Koeffler HP Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/macro-phages. Leukemia. 1993;7(10):1525–1530.
   PubMed Web of Science ®Google Scholar
• Schuitemaker H, Kootstra NA, Koppelman MH, et al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest. 1992;89(4)1154–1160.
   Web of Science ®Google Scholar
• Teichmann J, Stephan E, Lange U, et al. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect. 2003;46(4):221–227.
   PubMed Web of Science ®Google Scholar
• Bang UC, Shakar SA, Hitz MF, et al. Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis. 2010;42(4):306–310.
   PubMed Web of Science ®Google Scholar
• Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral ther-apy. AIDS Res Hum Retroviruses. 2008;24(11):1375–1382.
   PubMed Web of Science ®Google Scholar
• Arpadi SM, McMahon D, Abrams EJ, et al. Effect of bimonthly supplementation with oral cholecalcif-erol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics. 2009;123(1):e121–el 26.
   Web of Science ®Google Scholar
• von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol. 2010; 11 (4):344–349.
   PubMed Web of Science ®Google Scholar
• Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardio-vascular events: meta-analysis. BMJ. 2010;341:c3691.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regula-tory T cells and immune tolerance. Cell. 2008;133(5): 775–787.
   PubMed Web of Science ®Google Scholar
• Tsunemi S, Iwasaki T, Imado T, et al. Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS. 2005;19(9):879–886.
   PubMed Web of Science ®Google Scholar
• Del Pozo-Balado MM, Leal M, Mendez-Lagares G, Pacheco YM. CD4(+)CD25(±/hi)CD127(1o) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. J Infect Dis. 2010;201(3): 331–335.
   PubMed Web of Science ®Google Scholar
• Lin H, Sun XF, Zhen ZJ et al. [Correlation between periph-eral blood CD4+CD25high CD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphoma]. Ai Zheng. 2009;28(11):1186–1192.
   PubMedGoogle Scholar
• Xiong XZ, Jin Y, Zhou Q et al. [Correlation between FoxP3(+) regulatory T cells and chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi. 2008;88(7): 471–474.
   PubMedGoogle Scholar
• Barcelo B, Pons J, Ferrer JM, Sauleda J, Fuster A, Agusti AG. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J. 2008;31(3):555–562.
   PubMed Web of Science ®Google Scholar